Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
52
FFIV Quote, Financials, Valuation and Earnings
Last price:
$300.33
Seasonality move
:
2.87%
Day range:
$293.13 - $301.21
52-week range:
$170.21 - $313.00
Dividend yield:
0%
P/E ratio:
28.50x
P/S ratio:
6.03x
P/B ratio:
5.20x
Volume:
542.1K
Avg. volume:
439.7K
1-year change:
66.47%
Market cap:
$17.2B
Revenue:
$2.8B
EPS (TTM):
$10.54
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.6B | $2.7B | $2.8B | $2.8B | |
| Revenue Growth (YoY) | 4.83% | 10.75% | 3.55% | 4.35% | 0.11% | |
| Cost of Revenues | $407.9M | $493.1M | $539.6M | $593.3M | $557.6M | |
| Gross Profit | $1.9B | $2.1B | $2.2B | $2.2B | $2.3B | |
| Gross Profit Margin | 82.65% | 81.06% | 79.98% | 78.91% | 80.2% | |
| R&D Expenses | $441.3M | $512.6M | $543.4M | $540.3M | $490.1M | |
| Selling, General & Admin | $1.1B | $1.2B | $1.2B | $1.1B | $1.1B | |
| Other Inc / (Exp) | -$3.7M | -$7.1M | -$26.3M | -$52M | $28.2M | |
| Operating Expenses | $1.5B | $1.7B | $1.7B | $1.7B | $1.6B | |
| Operating Income | $400.1M | $394M | $411.7M | $538M | $667.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $396.4M | $386.9M | $385.4M | $486M | $695.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $89M | $55.7M | $63.2M | $91M | $128.7M | |
| Net Income to Company | $307.4M | $331.2M | $322.2M | $394.9M | $566.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $307.4M | $331.2M | $322.2M | $394.9M | $566.8M | |
| Basic EPS (Cont. Ops) | $5.05 | $5.46 | $5.34 | $6.59 | $9.65 | |
| Diluted EPS (Cont. Ops) | $5.01 | $5.34 | $5.27 | $6.55 | $9.55 | |
| Weighted Average Basic Share | $60.9M | $60.7M | $60.3M | $59.9M | $58.7M | |
| Weighted Average Diluted Share | $61.4M | $62.1M | $61.1M | $60.3M | $59.4M | |
| EBITDA | $495.9M | $509.4M | $527.3M | $650.7M | $774.2M | |
| EBIT | $400.1M | $394M | $411.7M | $538M | $667.2M | |
| Revenue (Reported) | $2.4B | $2.6B | $2.7B | $2.8B | $2.8B | |
| Operating Income (Reported) | $400.1M | $394M | $411.7M | $538M | $667.2M | |
| Operating Income (Adjusted) | $400.1M | $394M | $411.7M | $538M | $667.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $645.3M | $634.2M | $703.2M | $681.4M | $731.1M | |
| Revenue Growth (YoY) | 10.6% | -1.71% | 10.87% | -3.1% | 7.3% | |
| Cost of Revenues | $128.6M | $126.4M | $155.7M | $141.1M | $141M | |
| Gross Profit | $516.7M | $507.9M | $547.5M | $540.2M | $590.2M | |
| Gross Profit Margin | 80.07% | 80.08% | 77.86% | 79.29% | 80.72% | |
| R&D Expenses | $140.5M | $135.8M | $141.4M | $122.2M | $136.6M | |
| Selling, General & Admin | $322.7M | $297.4M | $300.1M | $278M | $294.7M | |
| Other Inc / (Exp) | -$1.4M | -$1.9M | $2.7M | $5.9M | $12.3M | |
| Operating Expenses | $463.2M | $433.2M | $441.5M | $400.2M | $431.3M | |
| Operating Income | $53.5M | $74.6M | $106M | $140.1M | $158.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $52.1M | $72.7M | $108.8M | $145.9M | $171.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $8.9M | $16.5M | $27.3M | $26.9M | $25.7M | |
| Net Income to Company | $43.2M | $56.2M | $81.4M | $119M | $145.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $43.2M | $56.2M | $81.4M | $119M | $145.5M | |
| Basic EPS (Cont. Ops) | $0.71 | $0.93 | $1.35 | $2.02 | $2.51 | |
| Diluted EPS (Cont. Ops) | $0.70 | $0.92 | $1.34 | $2.00 | $2.48 | |
| Weighted Average Basic Share | $60.7M | $60.6M | $60.3M | $58.8M | $57.9M | |
| Weighted Average Diluted Share | $62.2M | $61.4M | $60.7M | $59.6M | $58.8M | |
| EBITDA | $82M | $104.2M | $133.4M | $168.1M | $181.4M | |
| EBIT | $53.5M | $74.6M | $106M | $140.1M | $158.9M | |
| Revenue (Reported) | $645.3M | $634.2M | $703.2M | $681.4M | $731.1M | |
| Operating Income (Reported) | $53.5M | $74.6M | $106M | $140.1M | $158.9M | |
| Operating Income (Adjusted) | $53.5M | $74.6M | $106M | $140.1M | $158.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.7B | $2.8B | $2.8B | $2.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $461.6M | $511M | $588.9M | $560.1M | $561.6M | |
| Gross Profit | $2B | $2.1B | $2.2B | $2.2B | $2.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $490.9M | $524.1M | $560.9M | $498.4M | $515.4M | |
| Selling, General & Admin | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | |
| Other Inc / (Exp) | -$3M | -$17.3M | -$15.3M | -$43.4M | $25.9M | |
| Operating Expenses | $1.6B | $1.7B | $1.8B | $1.6B | $1.6B | |
| Operating Income | $357.5M | $419.5M | $421M | $645M | $729.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $354.5M | $402.2M | $405.7M | $601.6M | $755.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $76M | $52.1M | $79.5M | $103.1M | $134M | |
| Net Income to Company | $278.5M | $350.1M | $326.2M | $498.5M | $621.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $278.5M | $350.1M | $326.2M | $498.5M | $621.4M | |
| Basic EPS (Cont. Ops) | $4.56 | $5.79 | $5.43 | $8.41 | $10.65 | |
| Diluted EPS (Cont. Ops) | $4.51 | $5.69 | $5.40 | $8.35 | $10.54 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $466.4M | $538.5M | $531.6M | $760.2M | $824.4M | |
| EBIT | $357.5M | $419.5M | $421M | $645M | $729.5M | |
| Revenue (Reported) | $2.5B | $2.7B | $2.8B | $2.8B | $2.9B | |
| Operating Income (Reported) | $357.5M | $419.5M | $421M | $645M | $729.5M | |
| Operating Income (Adjusted) | $357.5M | $419.5M | $421M | $645M | $729.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.4B | $1.4B | $1.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $243.6M | $261.4M | $310.7M | $277.5M | $281.5M | |
| Gross Profit | $1B | $1.1B | $1.1B | $1.1B | $1.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $254.6M | $266.1M | $283.7M | $241.8M | $267.1M | |
| Selling, General & Admin | $600.4M | $597.1M | $603.2M | $541.6M | $573.8M | |
| Other Inc / (Exp) | -$2.1M | -$12.3M | -$1.3M | $7.3M | $4.9M | |
| Operating Expenses | $855.1M | $863.2M | $886.9M | $783.4M | $840.8M | |
| Operating Income | $171.2M | $196.7M | $206M | $313M | $375.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $169.2M | $184.4M | $204.7M | $320.3M | $380.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $38.3M | $34.6M | $50.9M | $62.9M | $68.3M | |
| Net Income to Company | $130.9M | $149.8M | $153.8M | $257.4M | $312M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $130.9M | $149.8M | $153.8M | $257.4M | $312M | |
| Basic EPS (Cont. Ops) | $2.14 | $2.47 | $2.55 | $4.36 | $5.36 | |
| Diluted EPS (Cont. Ops) | $2.11 | $2.43 | $2.54 | $4.32 | $5.30 | |
| Weighted Average Basic Share | $122.1M | $121.4M | $120.4M | $117.9M | $116.2M | |
| Weighted Average Diluted Share | $124.4M | $123.3M | $121.1M | $119.2M | $117.8M | |
| EBITDA | $227.4M | $256.5M | $260.8M | $370.3M | $420.4M | |
| EBIT | $171.2M | $196.7M | $206M | $313M | $375.3M | |
| Revenue (Reported) | $1.3B | $1.3B | $1.4B | $1.4B | $1.5B | |
| Operating Income (Reported) | $171.2M | $196.7M | $206M | $313M | $375.3M | |
| Operating Income (Adjusted) | $171.2M | $196.7M | $206M | $313M | $375.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $849.6M | $581M | $758M | $797.2M | $1.1B | |
| Short Term Investments | $360.3M | $329.6M | $126.6M | $6.2M | -- | |
| Accounts Receivable, Net | $296.2M | $340.5M | $470M | $454.8M | $389M | |
| Inventory | $27.9M | $22.1M | $68.4M | $35.9M | $76.4M | |
| Prepaid Expenses | $47.2M | $59.6M | $57.3M | $84.5M | $93.5M | |
| Other Current Assets | $44.6M | $28.6M | $77.6M | $64.9M | $42.2M | |
| Total Current Assets | $1.8B | $1.6B | $1.9B | $1.8B | $2.1B | |
| Property Plant And Equipment | $529.9M | $436.1M | $395.7M | $365.9M | $329.1M | |
| Long-Term Investments | $102.9M | $132.8M | $9.5M | $5.1M | $8.6M | |
| Goodwill | $1.9B | $2.2B | $2.3B | $2.3B | $2.3B | |
| Other Intangibles | $225.9M | $237.2M | $200.3M | $151M | $111.6M | |
| Other Long-Term Assets | $18.4M | $32.9M | $48.5M | $55.5M | $64.4M | |
| Total Assets | $4.7B | $5B | $5.3B | $5.2B | $5.6B | |
| Accounts Payable | $64.5M | $62.1M | $113.2M | $63.3M | $67.9M | |
| Accrued Expenses | $242.3M | $248.1M | $226.1M | $207M | $221.1M | |
| Current Portion Of Long-Term Debt | $19.3M | $19.3M | $349.8M | -- | -- | |
| Current Portion Of Capital Lease Obligations | $46M | $49.3M | $42.5M | $41.4M | $33.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.3B | $1.4B | $1.8B | $1.5B | $1.5B | |
| Long-Term Debt | $369M | $349.8M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.4B | $2.6B | $2.8B | $2.4B | $2.5B | |
| Common Stock | $305.5M | $192.5M | $91M | $24.4M | $5.9M | |
| Other Common Equity Adj | -$18.7M | -$20.1M | -$26.2M | -$23.2M | -$20.9M | |
| Common Equity | $2.2B | $2.4B | $2.5B | $2.8B | $3.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.2B | $2.4B | $2.5B | $2.8B | $3.1B | |
| Total Liabilities and Equity | $4.7B | $5B | $5.3B | $5.2B | $5.6B | |
| Cash and Short Terms | $1.2B | $910.6M | $884.6M | $803.3M | $1.1B | |
| Total Debt | $388.3M | $369M | $349.8M | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $532.2M | $586.5M | $734.5M | $902.7M | $1.3B | |
| Short Term Investments | $111.1M | $300.6M | $20.7M | $802K | -- | |
| Accounts Receivable, Net | $374.4M | $414.2M | $485.6M | $388.3M | $379.6M | |
| Inventory | $24.6M | $27.9M | $50.7M | $69.8M | $67.9M | |
| Prepaid Expenses | $62.9M | $96.2M | $87.4M | $116.6M | $98.6M | |
| Other Current Assets | $37.3M | $23.9M | $74.1M | $63M | $69M | |
| Total Current Assets | $1.3B | $1.7B | $1.8B | $2B | $2.3B | |
| Property Plant And Equipment | $468M | $406.3M | $386.1M | $350.5M | $338.5M | |
| Long-Term Investments | $19.1M | $34.9M | $4.7M | $6.3M | $12.5M | |
| Goodwill | $2.2B | $2.3B | $2.3B | $2.3B | $2.3B | |
| Other Intangibles | $273.5M | $224.5M | $178.1M | $132.2M | $92.7M | |
| Other Long-Term Assets | $19.7M | $38.4M | $51M | $55.9M | $68.1M | |
| Total Assets | $4.5B | $5.1B | $5.2B | $5.4B | $5.9B | |
| Accounts Payable | $53.6M | $69.1M | $70M | $57.7M | $43.6M | |
| Accrued Expenses | $239.6M | $221.6M | $213.9M | $201.5M | $217.2M | |
| Current Portion Of Long-Term Debt | $19.3M | $359.4M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $48.7M | $46M | $43.2M | $38.5M | $30.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.3B | $1.8B | $1.5B | $1.5B | $1.5B | |
| Long-Term Debt | $359.4M | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.5B | $2.7B | $2.5B | $2.5B | $2.6B | |
| Common Stock | $39.5M | $82.1M | $190.6M | $19M | $40.3M | |
| Other Common Equity Adj | -$19.2M | -$22.6M | -$23M | -$21M | -$22.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2B | $2.4B | $2.7B | $2.9B | $3.3B | |
| Total Liabilities and Equity | $4.5B | $5.1B | $5.2B | $5.4B | $5.9B | |
| Cash and Short Terms | $643.3M | $887.1M | $755.3M | $903.5M | $1.3B | |
| Total Debt | $378.7M | $359.4M | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $307.4M | $331.2M | $322.2M | $394.9M | $566.8M | |
| Depreciation & Amoritzation | $95.9M | $115.4M | $115.6M | $112.7M | $107M | |
| Stock-Based Compensation | $201.9M | $243.3M | $249.2M | $236.7M | $219.1M | |
| Change in Accounts Receivable | $46.5M | -$46.3M | -$130.6M | $16.7M | $64M | |
| Change in Inventories | $6.5M | $5.8M | -$46.3M | $32.5M | -$40.5M | |
| Cash From Operations | $660.9M | $645.2M | $442.6M | $653.4M | $792.4M | |
| Capital Expenditures | $59.9M | $30.7M | $33.6M | $54.2M | $30.4M | |
| Cash Acquisitions | -$955.6M | -$411.3M | -$67.9M | -$35M | -$32.9M | |
| Cash From Investing | -$747M | -$445.3M | $218.1M | $36.4M | -$59.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $400M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$10M | -$20M | -$20M | -$350M | -- | |
| Repurchase of Common Stock | -$100M | -$500M | -$500M | -$350M | -$500.6M | |
| Other Financing Activities | -$5.6M | -$14M | -$21M | -$13.2M | -$11.5M | |
| Cash From Financing | $337.2M | -$468.3M | -$476.5M | -$653.3M | -$457M | |
| Beginning Cash (CF) | $602.3M | $852.8M | $584.3M | $762.2M | $800.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $251.1M | -$268.4M | $184.2M | $36.5M | $276.2M | |
| Ending Cash (CF) | $852.8M | $584.3M | $762.2M | $800.8M | $1.1B | |
| Levered Free Cash Flow | $601M | $614.5M | $409M | $599.2M | $762M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $43.2M | $56.2M | $81.4M | $119M | $145.5M | |
| Depreciation & Amoritzation | $28.5M | $29.5M | $27.3M | $28M | $22.5M | |
| Stock-Based Compensation | $63.2M | $64.1M | $64M | $55.1M | $58.9M | |
| Change in Accounts Receivable | -$25.2M | $4.4M | $1.5M | $125.3M | $105.5M | |
| Change in Inventories | $1.9M | -$7.1M | $8.5M | -$33.9M | $5.4M | |
| Cash From Operations | $128.5M | $126.5M | $140.9M | $221.6M | $256.6M | |
| Capital Expenditures | $9.4M | $5.2M | $10.7M | $9.5M | $10.5M | |
| Cash Acquisitions | -$410.1M | -- | -$35M | -$32.9M | -$10.1M | |
| Cash From Investing | -$115.1M | $79.9M | -$9.5M | -$39.9M | -$20.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$5M | -$5M | -- | -- | -- | |
| Repurchase of Common Stock | -$500M | -$125M | -- | -$100M | -$127.1M | |
| Other Financing Activities | -$3.4M | -$3.2M | -$2.8M | -$1.8M | -$2.7M | |
| Cash From Financing | -$507M | -$132.2M | -$2.5M | -$101.2M | -$129.6M | |
| Beginning Cash (CF) | $1B | $515.8M | $610M | $826.3M | $1.2B | |
| Foreign Exchange Rate Adjustment | -$1.2M | -$136K | -$100K | -$485K | $2M | |
| Additions / Reductions | -$493.6M | $74.2M | $128.9M | $80.6M | $106.4M | |
| Ending Cash (CF) | $535.5M | $589.9M | $738.7M | $906.4M | $1.3B | |
| Levered Free Cash Flow | $119.1M | $121.3M | $130.2M | $212.2M | $246.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $278.5M | $350.1M | $326.2M | $498.5M | $621.4M | |
| Depreciation & Amoritzation | $108.9M | $119M | $110.6M | $115.2M | $94.8M | |
| Stock-Based Compensation | $224.8M | $249.9M | $248.2M | $220.9M | $224.8M | |
| Change in Accounts Receivable | -$37.5M | -$39.4M | -$72.1M | $97.6M | $4.7M | |
| Change in Inventories | $6.4M | -$3.3M | -$22.9M | -$19M | $1.9M | |
| Cash From Operations | $600.9M | $596.2M | $524.3M | $741.8M | $864.8M | |
| Capital Expenditures | $38.6M | $32.4M | $41.6M | $48.9M | $30.5M | |
| Cash Acquisitions | -$411.3M | -$67.9M | -$35M | -$33M | -$10.1M | |
| Cash From Investing | -$125.4M | -$313M | $232.6M | -$63M | -$42.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$20M | -$20M | -$360M | -- | -- | |
| Repurchase of Common Stock | -$550M | -$250M | -$290M | -$560.1M | -$502.6M | |
| Other Financing Activities | -$10.5M | -$22.9M | -$14M | -$12.1M | -$18.9M | |
| Cash From Financing | -$520.4M | -$227.3M | -$605.7M | -$512.1M | -$465.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$44.9M | $56M | $151.2M | $166.7M | $356.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $562.4M | $563.9M | $482.7M | $692.9M | $834.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $130.9M | $149.8M | $153.8M | $257.4M | $312M | |
| Depreciation & Amoritzation | $56.2M | $59.8M | $54.8M | $57.3M | $45.1M | |
| Stock-Based Compensation | $121.3M | $127.9M | $126.9M | $111.1M | $116.8M | |
| Change in Accounts Receivable | -$79.6M | -$72.8M | -$14.3M | $66.6M | $7.3M | |
| Change in Inventories | $3.3M | -$5.8M | $17.6M | -$33.9M | $8.5M | |
| Cash From Operations | $265.8M | $216.9M | $298.6M | $387M | $459.4M | |
| Capital Expenditures | $14.1M | $15.8M | $23.8M | $18.5M | $18.6M | |
| Cash Acquisitions | -$411.3M | -$67.9M | -$35M | -$32.9M | -$10.1M | |
| Cash From Investing | -$94.4M | $37.9M | $52.4M | -$47M | -$30.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$10M | -$10M | -$350M | -- | -- | |
| Repurchase of Common Stock | -$500M | -$250M | -$40M | -$250M | -$252.1M | |
| Other Financing Activities | -$7.9M | -$16.8M | -$9.8M | -$8.7M | -$16.1M | |
| Cash From Financing | -$489.2M | -$248.2M | -$377.4M | -$236.1M | -$244.3M | |
| Beginning Cash (CF) | $1.9B | $1.1B | $1.4B | $1.6B | $2.2B | |
| Foreign Exchange Rate Adjustment | $494K | -$997K | $3M | $1.8M | -$1.6M | |
| Additions / Reductions | -$317.8M | $6.6M | -$26.4M | $103.8M | $184.5M | |
| Ending Cash (CF) | $1.6B | $1.1B | $1.3B | $1.7B | $2.4B | |
| Levered Free Cash Flow | $251.7M | $201.1M | $274.8M | $368.5M | $440.8M | |
Get FFIV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FFIV
Sector
P/E ratio
28.50x
23.84x
PEG ratio
1.09x
0.00x
P/B ratio
5.20x
2.31x
Price / LTM sales
6.03x
1.64x
Growth Metrics
FFIV
Sector
Revenue growth
7.3%
3.84%
Earnings growth
24%
10.8%
Revenue (5-year growth)
4.66%
6.27%
Earnings forecast
$3.49
$0.12
Profitability
FFIV
Sector
Profitability FY 2024
$2.3B
$77.3M
Return on invested capital
19.89%
0.05%
Return on assets
11.01%
-0.48%
Return on equity
19.89%
0.73%
Earnings Date
Last Earnings Date
Apr
28
Next Earnings Date
Jul
30
Estimated Next Earnings Date
Jul
28
Balance Sheet
FFIV
Sector
Total cash
$1.3B
$48.7M
Short term investments
--
$19.4M
Total assets
$5.6B
$223.8M
Long term debt
--
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
